An Ottawa-area pot firm targeting the cannabis industry’s female consumers has secured a production licence from Health Canada.
Now certified, Fleurish Cannabis will begin cultivation of cannabis strains at its 20,000-square-foot facility in Kemptville. Roughly 75 per cent of the site will be dedicated to growing with the remainder acting as an R&D space for the firm.
At full capacity, the facility is expected to produce 1,400 kilograms of cannabis per year.
(Sponsored)
How The Ottawa Hospital uses AI tools to boost health outcomes and streamline clinical efficiency
Dr. Douglas Manuel says it all began with the Ottawa Ankle Rules algorithm, a set of clinical guidelines developed in the early 1990s by The Ottawa Hospital’s Dr. Ian Stiell
Local businesses face hiring obstacles due to immigration pullback, flawed screening
In his 39 years of practicing immigration law, Warren Creates (a rare Law Society Certified Specialist) has never seen an environment so challenging for employers looking to hire workers from
Fleurish will develop cannabis products such as dried flowers, pre-rolls and edible oils targeted at women in both the medical and recreational markets in Canada. Founder Renee Ellison told OBJ the firm’s surveys of female consumers revealed that women prefer different cannabis experiences such as topical ointments and other non-smokable options.
Chief marketing officer Mary Beth Williamson told OBJ earlier this year that Fleurish’s focus on women will help differentiate its offerings from larger incumbents.
“We are the only company exclusively targeting the health and wellness of women. When you’re unique, that is much more distinctive and stands out more,” she said.
Fleurish has raised roughly $7 million in private financing and was noted to be pursuing some 200,000 square feet of space for a larger cultivation facility, but Quinte News has reported the deal to secure such a site in Belleville has fallen through.
